Pfizer Inc (PFE) is a Healthcare · Drug Manufacturers - General company listed on NYSE. Price $27.66 (+0.07%), Market cap $147.90B, P/E ratio 19.81, 52-week low–high $23.12 ~ $28.55.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeu
Financial statements, price targets, institutional (13F) holdings and related news for Pfizer Inc are updated in real time on BlackAll Trade.
Pfizer Inc trades at $27.66 (+0.07%). Real-time quotes and charts are available on BlackAll Trade.
Pfizer Inc has a market cap of about $147.90B. Its P/E ratio is 19.81.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and P